Analysts Cut Lupin’s Target Price After Surprise Loss In Q2
Brightly coloured pharmaceutical medication, including antibiotics, paracetamol, Ibuprofen and cold relief tablets, in the U.K. (Photographer: Chris Ratcliffe/Bloomberg)

Analysts Cut Lupin’s Target Price After Surprise Loss In Q2

Most analysts cut target price for Lupin Ltd. after the nation’s third-largest drugmaker reported a surprise loss in the quarter ended September.Net loss stood at Rs 127 crore compared with a profi...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.